VanEck Biotech ETF (BBH) |
| 208.785 -1.314 (-0.63%) 07-29 12:21 |
| Open: | 209.82 |
| High: | 210.62 |
| Low: | 208.62 |
| Volume: | 3,664 |
| Market Cap: | 406(M) |
| PE Ratio: | 25.94 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 248.25 |
| Resistance 1: | 212.54 |
| Pivot price: | 205.10 |
| Support 1: | 199.82 |
| Support 2: | 191.96 |
| 52w High: | 212.54 |
| 52w Low: | 156.45 |
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 28 Jul 2026
Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees - The Motley Fool
Thu, 23 Jul 2026
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? - The Motley Fool
Thu, 23 Jul 2026
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? - The Globe and Mail
Tue, 14 Jul 2026
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? - The Motley Fool
Mon, 13 Jul 2026
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Tue, 23 Jun 2026
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
